Literature DB >> 21057163

G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients.

Rocio Aller1, Daniel Antonio de Luis, Olatz Izaola, Manuel González Sagrado, Rosa Conde, Tomas Alvarez Gago, David Pacheco, Jose Manuel González, María Concepcion Velasco.   

Abstract

Some studies have pointed to a role of TNF-alpha in pathogenesis of non alcoholic fatty liver disease (NAFLD). The aim of our study was to investigate the influence of G308A polymorphism TNF alpha gene on the histological changes, insulin resistance and TNF-alpha levels in overweight patients. A population of 66 patients with NAFLD was recruited in a cross sectional study. A biochemical analysis of serum was measured. Genotype of TNF alpha gene G308A was studied. Fifteen patients (22.7%) had the genotype G308A (mutant type group) and 51 patients (77.3%) G308G (wild type group). Patients with mutant type group presented more moderate-severe portal inflammation (86.7%) in liver biopsy compared to patient with wild genotype (19.7%). Mutant type group had more moderate-severe fibrosis (73.3%) than wild type group (51.3%). The multivariate analysis adjusted by age, sex, BMI and genotype with the dependent variable (fibrosis) showed that HOMA remained in the model, with an increase of the probability to develop fibrosis of 1.78 (CI95%:1.06-3.2) and develop moderate-severe inflammation of 1.45 (CI95%:1.02-2.1) with each increase of one unit on HOMA levels. In conclusion, Patients with mutant genotype have more frequently moderate-severe portal inflammation and fibrosis than wild type genotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057163

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  7 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease.

Authors:  Kayleigh L Wood; Michael H Miller; John F Dillon
Journal:  BMJ Open Gastroenterol       Date:  2015-02-17

4.  Meta-analysis of tumor necrosis factor alpha -308 polymorphism and knee osteoarthritis risk.

Authors:  Suotang Kou; Yaochi Wu
Journal:  BMC Musculoskelet Disord       Date:  2014-11-15       Impact factor: 2.362

5.  Omentin-1 rs2274907 and resistin rs1862513 polymorphisms influence genetic susceptibility to nonalcoholic fatty liver disease.

Authors:  Leila Kohan; Mehrnush Safarpur; Hamed Abdollahi
Journal:  Mol Biol Res Commun       Date:  2016-03

Review 6.  The Wide and Complex Field of NAFLD Biomarker Research: Trends.

Authors:  Erika Wichro; Tanja Macheiner; Jasmin Schmid; Barbara Kavsek; Karine Sargsyan
Journal:  ISRN Hepatol       Date:  2014-04-28

7.  Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients.

Authors:  Noha G Bader El Din; Sally Farouk; Reem El-Shenawy; Marwa K Ibrahim; Reham M Dawood; Mostafa M Elhady; Ahmed M Salem; Naglaa Zayed; Ahmed Khairy; Mostafa K El Awady
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.